Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 1. Scheme for classifying renal function without access to laboratory test results. <sup>*</sup>Renal-specific drugs: phosphate binders (ATC codes.

Published byEmory Fletcher Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 1. Scheme for classifying renal function without access to laboratory test results. <sup>*</sup>Renal-specific drugs: phosphate binders (ATC codes."— Presentation transcript:

1 Fig. 1. Scheme for classifying renal function without access to laboratory test results. <sup>*</sup>Renal-specific drugs: phosphate binders (ATC codes A12AA, V03AE02, V03AE03, V03AE04), active vitamin D (A11CC03, A11CC04), sodium bicarbonate (A02AH), erythropoiesis-stimulating agents (B03XA). From: A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records Clin Kidney J. Published online August 02, doi: /ckj/sfx085 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

2 Fig. 2. Distribution of eGFR values among 1
Fig. 2. Distribution of eGFR values among 1.1 million patients in the SCREAM cohort, Stockholm County, Sweden. From: A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records Clin Kidney J. Published online August 02, doi: /ckj/sfx085 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

3 Fig. 3. Creatinine-based eGFR values in relation to age among 1
Fig. 3. Creatinine-based eGFR values in relation to age among 1.1 million inhabitants in Stockholm County, Sweden. From: A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records Clin Kidney J. Published online August 02, doi: /ckj/sfx085 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

4 Fig. 4. Correspondence between the SCREAM-scheme classification of CKD stages versus creatinine-based eGFR values. From: A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records Clin Kidney J. Published online August 02, doi: /ckj/sfx085 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

5 Fig. 5. Scheme performance in relation to age.
From: A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records Clin Kidney J. Published online August 02, doi: /ckj/sfx085 Clin Kidney J | © The Author Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact

Download ppt "Fig. 1. Scheme for classifying renal function without access to laboratory test results. <sup>*</sup>Renal-specific drugs: phosphate binders (ATC codes."

Similar presentations

Figure 1 Alcohol consumption. A

Figure 1 Alcohol consumption. A
Fig. 4. Carer ratings of executive functioning (Dysexecutive Questionnaire) and memory (Memory Checklist) in the 3 groups at the beginning and end of the.

Fig. 4. Carer ratings of executive functioning (Dysexecutive Questionnaire) and memory (Memory Checklist) in the 3 groups at the beginning and end of the.
Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.

Table 1 Patient characteristics of attendees of the influenza vaccination, irrespective of AF status From: Yield of screening for atrial fibrillation in.
FIGURE 4: Mean change from baseline in iPTH concentration during treatment and 60 days after treatment withdrawal. Data are shown as the mean change ±

FIGURE 4: Mean change from baseline in iPTH concentration during treatment and 60 days after treatment withdrawal. Data are shown as the mean change ±
Fig. 1. Significant clusters in the amygdala and dlPFC, four-way interaction effect (group by valence by temperature by time), small volume corrected.

Fig. 1. Significant clusters in the amygdala and dlPFC, four-way interaction effect (group by valence by temperature by time), small volume corrected.
From: Dynamic De/Centralization in Canada, 1867–2010

From: Dynamic De/Centralization in Canada, 1867–2010
Figure 3: (a and b) Preoperative contrast-eCT

Figure 3: (a and b) Preoperative contrast-eCT
Figure 1 Proportion of criteria chosen (as percentages, grouped into issues). From: Developing national obesity policy in middle-income countries: a case.

Figure 1 Proportion of criteria chosen (as percentages, grouped into issues). From: Developing national obesity policy in middle-income countries: a case.
J Exp Bot. 2017;68(17): doi: /jxb/erx352

J Exp Bot. 2017;68(17): doi: /jxb/erx352
Figure 2. Chronic kidney disease risk tool application.

Figure 2. Chronic kidney disease risk tool application.
Fig 1 The CONSORT participant flow diagram for primary endpoints.

Fig 1 The CONSORT participant flow diagram for primary endpoints.
Figure 3: MetaLIMS sample input.

Figure 3: MetaLIMS sample input.
Figure 1 Study flow chart.

Figure 1 Study flow chart.
Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.

Figure 5: Three-dimensional reconstruction of the CT scan showing the trapped air in the head and neck region. From: Distinct subcutaneous emphysema following.
Figure 2. The graphic integration of CNAs with altered expression genes in lung AD and SCC. The red lines represent the amplification regions for CNA and.

Figure 2. The graphic integration of CNAs with altered expression genes in lung AD and SCC. The red lines represent the amplification regions for CNA and.
From: Learning by Working in Big Cities

From: Learning by Working in Big Cities
From: THE FALLACIES OF PATENT-HOLDUP THEORY

From: THE FALLACIES OF PATENT-HOLDUP THEORY
Fig. 1. Trial structure for the experimental task.

Fig. 1. Trial structure for the experimental task.
Fig. 1 Nodes in a conceptual knowledge graph

Fig. 1 Nodes in a conceptual knowledge graph
Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.

Figure 1: Pneumomediastinum and subcutaneous emphysema as indicated by the arrows. From: Pneumomediastinum and subcutaneous emphysema after successful.

Similar presentations

Ads by Google